Mankind Pharma shares skid 4% amid block deal buzz
Three private equity funds, namely Chrys Capital, Capital Group, and Everbridge Partners, were reportedly looking to sell stakes worth $592 million in Mankind Pharma via the block deal.
mankind pharma shares
December 2023
November 2023
August 2023
May 2023
April 2023
Mankind Pharma shares drop 3% post Q2
Mankind Pharma has reported 19.4% YoY rise in profit at ₹501.03 cr in Q2 FY24, while revenue from operations jumped 11.6% to ₹2,708.10 cr.
Mankind Pharma shares jump 10% on robust Q1; up 77% against IPO price
The pharma major reported 66% YoY growth in net profit at ₹494 crore, while sales rose 18% YoY to ₹2,579 crore in Q1FY24.
Mankind Pharma shares rise 2% on robust Q4 results
The newly listed pharma company reported 52% growth in profit at ₹294 crore, while revenue from operations rose 19% to ₹2,053 crore in Q4FY23.
Mankind Pharma shares nosedive 5% on report of I-T raid
The pharma stock, which made its market debut on May 9, has fallen as much as 9% in the last two sessions.
Mankind Pharma shares plunge 7% on day 2 after strong debut
Despite today’s fall, Mankind Pharma shares trade 23.5% higher than its initial public offering (IPO) price of ₹1,080 per share
Mankind Pharma sets price band for ₹4,326 cr IPO at ₹1026-1080 per share
The IPO of the pharma company will open for subscription on April 25 and close on April 27.
